Download RANDOMIZED CLINICAL TRIALS

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
RANDOMIZED CLINICAL
TRIALS
What is a randomized
clinical trial?
 Scientific investigations: examine and evaluate the safety and
efficacy of new drugs on human volunteers.
 Compare a new drug vs. existing drugs or placebo.
 designed in an ethical: voluntary consent.
 The results: the most valued data in the era of evidence-based
medicine.
Classification of clinical trials
Phases:
 Phase I, safety – tolerability – pharmacokinetic/dynamics –
dose/ response.
 Phase II, Dosing – Efficacy
 Phase III, Effcacy compared to gold standard treatment.
 Phase IV, post-marketing - pharmacovigilance.
Phase
I
Phase
II
Phase
III
Phase
IV
Classification of clinical trials
Trial design:
 Parallel-group, followed-up to determine the effect of each treatment
in parallel groups.
 Crossover, patients to different sequences of treatments.
 Factorial, assign patients to more than one treatment-comparison
group.
 Cluster randomized, larger groups are randomized instead of
individual patients.
Classification of clinical trials
Number of centres:
 Single-center.
 Multicenter.
What the study was designed to prove:
 Superiority study, new drug is more effective than
placebo.
 Equivalence study, how that two drugs have the same
clinical benefit.
 No inferiority study, new treatment cannot be said to be
significantly weaker.
Erroneous results
Bias/Systematic errors
 Design, conduct, analysis, and the results  associate
the occurrence of systematic errors for influenced by
bias.
 The bias can also make the trial-derived estimate of a
treatment effect deviate from its true value.
 Types of bias in clinical trials:
 Related to subject selection.
 outcome measurement.
 estimate bias.
Erroneous results
Random error
 The sampling error is produced because the
sample might yet show a chance false result.
 Reduced:
 choosing a very large group of patients.
 special analytic techniques (meta-analysis).
 Statistical testing involves an evolution of the
probability of obtaining the observed treatment
difference.
Erroneous results
Confounding
 Distortion of the real relationship: treatment and outcome by
another factor.
 Eliminate bias: the solution is randomization in conjunction.
 Before start the trial  delete the bias of confounding across
randomization techniques:
 stratified randomization confounding.
 regression analysis.
How develop a randomized
clinical trial?
1) Objectives and endpoints
 Clear objectives that are measured by endpoints.
2) Study design
 Type of trial design
 Minimize bias
3) Patient population
 Define number of patients.
 Exclude some patients.
 Informed consent.
How develop a randomized
clinical trial?
4) Sample size calculation
 used for minimize random error.
 For calculate: statistical models that take account of
the recruitment of patients into the trial and the type
of statistical test to be used.
5) Conduct of the trial
 Define the initial dose used of the study drug.
 the investigators recruit patients for the trial.
 Management, and coordination.
 Visits will scheduled every for X time.
How develop a randomized
clinical trial?
6) Interim monitoring
 Randomly assign patients: an independent statistician centre
(DSMB).
 DSMB has to make sure that the new drug that patients are
taking is not damaging.
7) Final data analysis
 All endpoints can analyse: the log-rank test, stratified and
displayed on Kaplan–Meier plots.
 Statistical analyses are usually stipulated in the trial protocol.
8) Trial reporting
 Results publish different reports, which follow the CONSORT
(Consolidated Standards of Reporting Trials).